PROCEPT BioRobotics Investor Relations Material

PROCEPT BioRobotics Corporation is a medical technology company specializing in the development and commercialization of robotic systems for the treatment of urological conditions. The company’s primary focus is on addressing benign prostatic hyperplasia (BPH), offering minimally invasive solutions designed to improve precision, patient outcomes, and recovery times. Its robotic platform combines imaging, robotics, and software to enhance surgical accuracy and efficiency, supporting healthcare providers in delivering advanced care. PROCEPT BioRobotics Corporation is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.